← TrialMatch
HomeTrials

The Effect of Progressive Muscle Relaxation Exercises on Depression and Fatigue in Patient

This study aims to evaluate the effects of progressive muscle relaxation exercises on depression and fatigue levels in patients undergoing hemodialysis treatment. Progressive muscle relaxation is applied as an individualized non-pharmacological intervention, and its potential contribution to psychological well-being is

Condition(s)Hemodialysis Complication, Hemodialysis
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThis study aims to evaluate the effects of progressive muscle relaxation exercises on depression and fatigue levels in patients undergoing hemodialysis treatment. Progressive muscle relaxation is applied as an individualized non-pharmacological intervention, and its potential contribution to psychological well-being is investigated. The study seeks to determine whether regular relaxation exercises can reduce depressive symptoms, alleviate fatigue, and improve overall emotional well-being in hemodialysis patients. Findings from this research are expected to provide evidence for the use of relaxation-based interventions as supportive care methods in the management of psychological symptoms associated with chronic kidney disease and hemodialysis.
Who can participateInclusion Criteria: Scoring 4 or above on the First-Level Beck Depression Inventory Patients who regularly receive hemodialysis treatment Individuals who are cognitively capable of understanding the exercise instructions Individuals who voluntarily agree to participate in the study and provide informed consent Exclusion Criteria: Individuals diagnosed with a psychiatric disorder (e.g., major depression, bipolar disorder, schizophrenia, etc.) Individuals who are physically unable to perform relaxation exercises due to musculoskeletal disorders Individuals who have previously participated regularly in relaxation therapy, yoga, meditation, or similar practices Individuals who cannot follow instructions due to hearing, visual, or cognitive impairments Individuals who are simultaneously partici
Ages18 Years to 75 Years
SexAll
Accepts healthy volunteersYes
Lead sponsorIstanbul Aydın University
LocationsIstanbul, Istanbul, Turkey (Türkiye); Istanbul, Turkey (Türkiye)
Start date2025-12-01
NCT IDNCT07512895
Official listinghttps://clinicaltrials.gov/study/NCT07512895

🔍 Search all trials →